Danaparoid: an anti-thrombotic agent without major impact on triglyceride hydrolysis capacity in humans
Mikhailidis I.A. Jagroop, Department of Chemical Pathology and Human Metabolism, Royal Free Hosptial and School of Medicine, Pond Street, London NW3 2QG, UK (Telephone: + 0171 794 0500 ext. 3481; fax: 0171 794 9537).
No abstract is available for this article.